{"count":220842,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=722","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=720","results":[{"created":"2022-10-06T17:28:12.607776+11:00","panel_name":"Ciliopathies","panel_id":84,"panel_version":"1.36","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SCNM1 as ready","entity_name":"SCNM1","entity_type":"gene"},{"created":"2022-10-06T17:28:12.600181+11:00","panel_name":"Ciliopathies","panel_id":84,"panel_version":"1.36","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: scnm1 has been classified as Green List (High Evidence).","entity_name":"SCNM1","entity_type":"gene"},{"created":"2022-10-06T17:26:11.256155+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4980","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GABRG1 were changed from  to Developmental and epileptic encephalopathy MONDO:0100062","entity_name":"GABRG1","entity_type":"gene"},{"created":"2022-10-06T17:25:35.908617+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4979","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GABRG1 were set to ","entity_name":"GABRG1","entity_type":"gene"},{"created":"2022-10-06T17:25:08.745729+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4978","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GABRG1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GABRG1","entity_type":"gene"},{"created":"2022-10-06T17:23:59.596287+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.481","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OSMR as ready","entity_name":"OSMR","entity_type":"gene"},{"created":"2022-10-06T17:23:59.587554+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.481","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: osmr has been classified as Red List (Low Evidence).","entity_name":"OSMR","entity_type":"gene"},{"created":"2022-10-06T17:23:55.923751+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.481","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: OSMR were changed from Amyloidosis, primary cutaneous to Amyloidosis, primary localized cutaneous, 1 - MIM#105250","entity_name":"OSMR","entity_type":"gene"},{"created":"2022-10-06T17:23:42.733245+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.480","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: OSMR as Red List (low evidence)","entity_name":"OSMR","entity_type":"gene"},{"created":"2022-10-06T17:23:42.726491+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.480","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: osmr has been classified as Red List (Low Evidence).","entity_name":"OSMR","entity_type":"gene"},{"created":"2022-10-06T17:23:30.369683+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.479","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: OSMR: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Amyloidosis, primary localized cutaneous, 1 - MIM#105250; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"OSMR","entity_type":"gene"},{"created":"2022-10-06T17:22:18.067861+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.378","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SLC32A1 were changed from Genetic epilepsy with febrile seizures plus to Genetic epilepsy with febrile seizures plus; Developmental and epileptic encephalopathy MONDO:0100062, SLC32A1-related","entity_name":"SLC32A1","entity_type":"gene"},{"created":"2022-10-06T17:22:02.519161+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.377","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SLC32A1 were set to 34038384","entity_name":"SLC32A1","entity_type":"gene"},{"created":"2022-10-06T17:21:31.123463+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1693","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SLC32A1 were set to 34038384; 36073542","entity_name":"SLC32A1","entity_type":"gene"},{"created":"2022-10-06T17:20:57.091184+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1692","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SLC32A1 were changed from Genetic epilepsy with febrile seizures plus to Genetic epilepsy with febrile seizures plus; Developmental and epileptic encephalopathy MONDO:0100062, SLC32A1-related","entity_name":"SLC32A1","entity_type":"gene"},{"created":"2022-10-06T17:20:31.659683+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1691","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: SLC32A1 were set to 34038384","entity_name":"SLC32A1","entity_type":"gene"},{"created":"2022-10-06T17:16:12.804907+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.479","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ORC1 as ready","entity_name":"ORC1","entity_type":"gene"},{"created":"2022-10-06T17:16:12.790591+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.479","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: orc1 has been classified as Red List (Low Evidence).","entity_name":"ORC1","entity_type":"gene"},{"created":"2022-10-06T17:16:09.600864+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.479","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ORC1 were changed from Meier-Gorlin syndrome to Meier-Gorlin syndrome 1, MIM# 224690","entity_name":"ORC1","entity_type":"gene"},{"created":"2022-10-06T17:15:56.386234+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.478","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ORC1 as Red List (low evidence)","entity_name":"ORC1","entity_type":"gene"},{"created":"2022-10-06T17:15:56.378872+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.478","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: orc1 has been classified as Red List (Low Evidence).","entity_name":"ORC1","entity_type":"gene"},{"created":"2022-10-06T17:15:44.044381+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.477","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ORC1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Meier-Gorlin syndrome 1, MIM# 224690; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ORC1","entity_type":"gene"},{"created":"2022-10-06T17:15:08.757189+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.477","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OPA1 as ready","entity_name":"OPA1","entity_type":"gene"},{"created":"2022-10-06T17:15:08.738962+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.477","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: opa1 has been classified as Red List (Low Evidence).","entity_name":"OPA1","entity_type":"gene"},{"created":"2022-10-06T17:15:03.027144+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.477","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: OPA1 were changed from Optic atrophy 1 to Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)MIM# 616896; Behr syndrome MIM#210000, AR; Optic atrophy 1, MIM#165500; Optic atrophy plus syndrome, MIM# 125250","entity_name":"OPA1","entity_type":"gene"},{"created":"2022-10-06T17:14:51.273252+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.476","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: OPA1 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal","entity_name":"OPA1","entity_type":"gene"},{"created":"2022-10-06T17:14:42.327082+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.475","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: OPA1 as Red List (low evidence)","entity_name":"OPA1","entity_type":"gene"},{"created":"2022-10-06T17:14:42.319978+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.475","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: opa1 has been classified as Red List (Low Evidence).","entity_name":"OPA1","entity_type":"gene"},{"created":"2022-10-06T17:14:31.049265+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.474","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: OPA1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)MIM# 616896, Behr syndrome MIM#210000, AR, Optic atrophy 1, MIM#165500, Optic atrophy plus syndrome, MIM# 125250; Mode of inheritance: BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal","entity_name":"OPA1","entity_type":"gene"},{"created":"2022-10-06T17:05:36.309296+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.474","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OFD1 as ready","entity_name":"OFD1","entity_type":"gene"},{"created":"2022-10-06T17:05:36.300522+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.474","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ofd1 has been classified as Red List (Low Evidence).","entity_name":"OFD1","entity_type":"gene"},{"created":"2022-10-06T17:05:27.137088+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.474","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: OFD1 were changed from Oral-facial-digital syndrome to Retinitis pigmentosa 23, MIM# 300424; Joubert syndrome 10, MIM# 300804; Orofaciodigital syndrome I, MIM# 311200","entity_name":"OFD1","entity_type":"gene"},{"created":"2022-10-06T17:05:12.723164+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.473","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: OFD1 as Red List (low evidence)","entity_name":"OFD1","entity_type":"gene"},{"created":"2022-10-06T17:05:12.716319+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.473","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ofd1 has been classified as Red List (Low Evidence).","entity_name":"OFD1","entity_type":"gene"},{"created":"2022-10-06T17:05:01.867069+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.472","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: OFD1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Retinitis pigmentosa 23, MIM# 300424, Joubert syndrome 10, MIM# 300804, Orofaciodigital syndrome I, MIM# 311200; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"OFD1","entity_type":"gene"},{"created":"2022-10-06T17:04:07.556151+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.472","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OCRL as ready","entity_name":"OCRL","entity_type":"gene"},{"created":"2022-10-06T17:04:07.549175+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.472","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ocrl has been classified as Red List (Low Evidence).","entity_name":"OCRL","entity_type":"gene"},{"created":"2022-10-06T17:04:03.507598+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.472","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: OCRL were changed from Lowe oculocerebrorenal syndrome to Dent disease 2, MIM# 300555; Lowe syndrome , MIM#309000","entity_name":"OCRL","entity_type":"gene"},{"created":"2022-10-06T17:03:50.461154+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.471","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: OCRL as Red List (low evidence)","entity_name":"OCRL","entity_type":"gene"},{"created":"2022-10-06T17:03:50.453994+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.471","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ocrl has been classified as Red List (Low Evidence).","entity_name":"OCRL","entity_type":"gene"},{"created":"2022-10-06T17:03:38.289010+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.470","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: OCRL: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Dent disease 2, MIM# 300555, Lowe syndrome , MIM#309000; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"OCRL","entity_type":"gene"},{"created":"2022-10-06T17:02:50.538849+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.470","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OCA2 as ready","entity_name":"OCA2","entity_type":"gene"},{"created":"2022-10-06T17:02:50.531430+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.470","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: oca2 has been classified as Red List (Low Evidence).","entity_name":"OCA2","entity_type":"gene"},{"created":"2022-10-06T17:02:47.531798+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.470","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: OCA2 were changed from Albinism, oculocutaneous to Albinism, brown oculocutaneous, MIM# 203200; Albinism, oculocutaneous, type II, MIM# 203200","entity_name":"OCA2","entity_type":"gene"},{"created":"2022-10-06T17:02:35.923533+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.469","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: OCA2 was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"OCA2","entity_type":"gene"},{"created":"2022-10-06T17:02:25.620797+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.468","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: OCA2 as Red List (low evidence)","entity_name":"OCA2","entity_type":"gene"},{"created":"2022-10-06T17:02:25.613349+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.468","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: oca2 has been classified as Red List (Low Evidence).","entity_name":"OCA2","entity_type":"gene"},{"created":"2022-10-06T17:02:13.256609+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.467","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: OCA2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Albinism, brown oculocutaneous, MIM# 203200, Albinism, oculocutaneous, type II, MIM# 203200; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"OCA2","entity_type":"gene"},{"created":"2022-10-06T17:01:24.599312+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.467","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: OBSL1 as ready","entity_name":"OBSL1","entity_type":"gene"},{"created":"2022-10-06T17:01:24.591713+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.467","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: obsl1 has been classified as Red List (Low Evidence).","entity_name":"OBSL1","entity_type":"gene"},{"created":"2022-10-06T17:01:20.301680+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.467","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: OBSL1 were changed from 3-M syndrome to 3-M syndrome 2, MIM #612921","entity_name":"OBSL1","entity_type":"gene"},{"created":"2022-10-06T17:01:08.191921+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.466","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: OBSL1 as Red List (low evidence)","entity_name":"OBSL1","entity_type":"gene"},{"created":"2022-10-06T17:01:08.179300+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.466","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: obsl1 has been classified as Red List (Low Evidence).","entity_name":"OBSL1","entity_type":"gene"},{"created":"2022-10-06T17:00:55.644143+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.465","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: OBSL1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: 3-M syndrome 2, MIM #612921; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"OBSL1","entity_type":"gene"},{"created":"2022-10-06T16:56:41.871699+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.465","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NTRK1 as ready","entity_name":"NTRK1","entity_type":"gene"},{"created":"2022-10-06T16:56:41.864736+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.465","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ntrk1 has been classified as Red List (Low Evidence).","entity_name":"NTRK1","entity_type":"gene"},{"created":"2022-10-06T16:56:33.491619+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.465","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NTRK1 as Red List (low evidence)","entity_name":"NTRK1","entity_type":"gene"},{"created":"2022-10-06T16:56:33.475408+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.465","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ntrk1 has been classified as Red List (Low Evidence).","entity_name":"NTRK1","entity_type":"gene"},{"created":"2022-10-06T16:56:21.513056+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.464","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NTRK1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Insensitivity to pain, congenital, with anhidrosis - MIM#256800; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NTRK1","entity_type":"gene"},{"created":"2022-10-06T16:55:20.382676+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.464","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NSD1 as ready","entity_name":"NSD1","entity_type":"gene"},{"created":"2022-10-06T16:55:20.374429+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.464","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nsd1 has been classified as Red List (Low Evidence).","entity_name":"NSD1","entity_type":"gene"},{"created":"2022-10-06T16:55:16.767286+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.464","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NSD1 were changed from Sotos syndrome to Sotos syndrome 1, MIM# 117550","entity_name":"NSD1","entity_type":"gene"},{"created":"2022-10-06T16:55:04.564691+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.463","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NSD1 as Red List (low evidence)","entity_name":"NSD1","entity_type":"gene"},{"created":"2022-10-06T16:55:04.555699+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.463","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nsd1 has been classified as Red List (Low Evidence).","entity_name":"NSD1","entity_type":"gene"},{"created":"2022-10-06T16:54:52.967752+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.462","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NSD1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Sotos syndrome 1, MIM# 117550; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NSD1","entity_type":"gene"},{"created":"2022-10-06T16:54:10.013313+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.462","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NR5A1 as ready","entity_name":"NR5A1","entity_type":"gene"},{"created":"2022-10-06T16:54:10.005555+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.462","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nr5a1 has been classified as Green List (High Evidence).","entity_name":"NR5A1","entity_type":"gene"},{"created":"2022-10-06T16:54:06.489188+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.462","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NR5A1 were changed from 46, XX sex reversal 4, MIM#\t617480; 46XY sex reversal 3, MIM#\t612965 to Adrenocortical insufficiency, (MIM#612964)","entity_name":"NR5A1","entity_type":"gene"},{"created":"2022-10-06T16:53:51.476444+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.461","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: NR5A1.","entity_name":"NR5A1","entity_type":"gene"},{"created":"2022-10-06T16:53:40.443456+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.461","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NR5A1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Adrenocortical insufficiency, (MIM#612964); Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NR5A1","entity_type":"gene"},{"created":"2022-10-06T16:52:43.096114+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.461","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NR3C2 as ready","entity_name":"NR3C2","entity_type":"gene"},{"created":"2022-10-06T16:52:43.087319+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.461","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nr3c2 has been classified as Green List (High Evidence).","entity_name":"NR3C2","entity_type":"gene"},{"created":"2022-10-06T16:52:33.733982+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.461","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NR3C2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Pseudohypoaldosteronism type I, autosomal dominant, MIM# 177735; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NR3C2","entity_type":"gene"},{"created":"2022-10-06T16:51:41.807293+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.461","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NR0B1 as ready","entity_name":"NR0B1","entity_type":"gene"},{"created":"2022-10-06T16:51:41.793146+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.461","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nr0b1 has been classified as Green List (High Evidence).","entity_name":"NR0B1","entity_type":"gene"},{"created":"2022-10-06T16:51:38.348867+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.461","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NR0B1 were changed from Congenital adrenal hypoplasia to Adrenal hypoplasia, congenital (MIM# 300200)","entity_name":"NR0B1","entity_type":"gene"},{"created":"2022-10-06T16:51:24.574680+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.460","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: NR0B1.","entity_name":"NR0B1","entity_type":"gene"},{"created":"2022-10-06T16:51:14.273179+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.460","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NR0B1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Adrenal hypoplasia, congenital (MIM# 300200); Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"NR0B1","entity_type":"gene"},{"created":"2022-10-06T16:49:08.452552+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.460","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NPHS1 as ready","entity_name":"NPHS1","entity_type":"gene"},{"created":"2022-10-06T16:49:08.444036+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.460","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nphs1 has been classified as Red List (Low Evidence).","entity_name":"NPHS1","entity_type":"gene"},{"created":"2022-10-06T16:49:04.644030+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.460","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NPHS1 were changed from Congenital nephrotic syndrome, Finnish type to Nephrotic syndrome, type 1, MIM# 256300","entity_name":"NPHS1","entity_type":"gene"},{"created":"2022-10-06T16:48:49.428454+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.459","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NPHS1 as Red List (low evidence)","entity_name":"NPHS1","entity_type":"gene"},{"created":"2022-10-06T16:48:49.419754+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.459","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nphs1 has been classified as Red List (Low Evidence).","entity_name":"NPHS1","entity_type":"gene"},{"created":"2022-10-06T16:48:31.469522+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.458","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NPHS1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Nephrotic syndrome, type 1, MIM# 256300; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NPHS1","entity_type":"gene"},{"created":"2022-10-06T16:47:48.187749+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.458","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NPHP4 as ready","entity_name":"NPHP4","entity_type":"gene"},{"created":"2022-10-06T16:47:48.179682+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.458","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nphp4 has been classified as Red List (Low Evidence).","entity_name":"NPHP4","entity_type":"gene"},{"created":"2022-10-06T16:47:44.231571+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.458","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NPHP4 were changed from Nephronophthisis to Nephronophthisis 4, MIM# 606966 Senior-Loken syndrome 4, MIM# 606996","entity_name":"NPHP4","entity_type":"gene"},{"created":"2022-10-06T16:47:27.968710+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.457","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NPHP4 as Red List (low evidence)","entity_name":"NPHP4","entity_type":"gene"},{"created":"2022-10-06T16:47:27.958123+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.457","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nphp4 has been classified as Red List (Low Evidence).","entity_name":"NPHP4","entity_type":"gene"},{"created":"2022-10-06T16:47:17.310562+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.456","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NPHP4: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Nephronophthisis 4, MIM# 606966 Senior-Loken syndrome 4, MIM# 606996; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NPHP4","entity_type":"gene"},{"created":"2022-10-06T16:46:38.700939+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.456","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NPHP3 as ready","entity_name":"NPHP3","entity_type":"gene"},{"created":"2022-10-06T16:46:38.690865+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.456","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nphp3 has been classified as Red List (Low Evidence).","entity_name":"NPHP3","entity_type":"gene"},{"created":"2022-10-06T16:46:34.923234+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.456","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NPHP3 were changed from Nephronophthisis to Renal-hepatic-pancreatic dysplasia 1, MIM# 208540","entity_name":"NPHP3","entity_type":"gene"},{"created":"2022-10-06T16:45:38.792855+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.455","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NPHP3: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Renal-hepatic-pancreatic dysplasia 1, MIM# 208540; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NPHP3","entity_type":"gene"},{"created":"2022-10-06T16:45:23.614949+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.455","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NPHP3 as Red List (low evidence)","entity_name":"NPHP3","entity_type":"gene"},{"created":"2022-10-06T16:45:23.605335+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.455","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nphp3 has been classified as Red List (Low Evidence).","entity_name":"NPHP3","entity_type":"gene"},{"created":"2022-10-06T16:28:42.413872+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.376","user_name":"Elena Savva","item_type":"entity","text":"Marked gene: SCNM1 as ready","entity_name":"SCNM1","entity_type":"gene"},{"created":"2022-10-06T16:28:42.405966+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.376","user_name":"Elena Savva","item_type":"entity","text":"Gene: scnm1 has been classified as Green List (High Evidence).","entity_name":"SCNM1","entity_type":"gene"},{"created":"2022-10-06T16:28:40.295028+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.376","user_name":"Elena Savva","item_type":"entity","text":"Classified gene: SCNM1 as Green List (high evidence)","entity_name":"SCNM1","entity_type":"gene"},{"created":"2022-10-06T16:28:40.287206+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.376","user_name":"Elena Savva","item_type":"entity","text":"Gene: scnm1 has been classified as Green List (High Evidence).","entity_name":"SCNM1","entity_type":"gene"}]}